Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma

被引:32
作者
Liu, Tang [1 ,2 ,3 ]
Shen, Jacson K. [1 ,2 ]
Li, Zhihong [3 ]
Choy, Edwin [1 ,2 ]
Hornicek, Francis J. [1 ,2 ]
Duan, Zhenfeng [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Orthopaed Surg, Sarcoma Biol Lab, 55 Fruit St,Jackson 1115, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, 55 Fruit St,Jackson 1115, Boston, MA 02114 USA
[3] Cent South Univ, Xiangya Hosp 2, Dept Orthopaed, 139 Renmin Rd, Changsha 410011, Hunan, Peoples R China
基金
美国国家卫生研究院;
关键词
CRISPR-Cas9; Sarcoma; Cancer modeling; Gene therapy; MOUSE MODEL; CHROMOSOMAL TRANSLOCATIONS; ANTITUMOR-ACTIVITY; CELLULAR-ORIGINS; NUCLEAR EXPORT; CANCER; P53; CRISPR/CAS9; TUMOR; EXPRESSION;
D O I
10.1016/j.canlet.2016.01.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sarcomas include some of the most aggressive tumors and typically respond poorly to chemotherapy. In recent years, specific gene fusion/mutations and gene over-expression/activation have been shown to drive sarcoma pathogenesis and development. These emerging genomic alterations may provide targets for novel therapeutic strategies and have the potential to transform sarcoma patient care. The RNA guided nuclease CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated protein-9 nuclease) is a convenient and versatile platform for site-specific genome editing and epigenome targeted modulation. Given that sarcoma is believed to develop as a result of genetic alterations in mesenchymal progenitor/stem cells, CRISPR-Cas9 genome editing technologies hold extensive application potentials in sarcoma models and therapies. We review the development and mechanisms of the CRISPR-Cas9 system in genome editing and introduce its application in sarcoma research and potential therapy in clinic. Additionally, we propose future directions and discuss the challenges faced with these applications, providing concise and enlightening information for readers interested in this area. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:109 / 118
页数:10
相关论文
共 50 条
[31]   Genome characterization and CRISPR-Cas9 editing of a human neocentromere [J].
Antonio Palazzo ;
Ilaria Piccolo ;
Crescenzio Francesco Minervini ;
Stefania Purgato ;
Oronzo Capozzi ;
Pietro D’Addabbo ;
Cosimo Cumbo ;
Francesco Albano ;
Mariano Rocchi ;
Claudia Rita Catacchio .
Chromosoma, 2022, 131 :239-251
[32]   Optimization of genome editing through CRISPR-Cas9 engineering [J].
Zhang, Jian-Hua ;
Adikaram, Poorni ;
Pandey, Mritunjay ;
Genis, Allison ;
Simonds, William F. .
BIOENGINEERED, 2016, 7 (03) :166-174
[33]   Development of an Efficient Genome Editing Tool in Bacillus licheniformis Using CRISPR-Cas9 Nickase [J].
Li, Kaifeng ;
Cai, Dongbo ;
Wang, Zhangqian ;
He, Zhili ;
Chen, Shouwen .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2018, 84 (06)
[34]   Temperature effect on CRISPR-Cas9 mediated genome editing [J].
Guanghai Xiang ;
Xingying Zhang ;
Chenrui An ;
Chen Cheng ;
Haoyi Wang .
JournalofGeneticsandGenomics, 2017, 44 (04) :199-205
[35]   Genome editing of Francisella tularensis using (CRISPR-Cas9) [J].
Southern, Stephanie J. ;
Oyston, Petra C. F. .
JOURNAL OF MICROBIOLOGICAL METHODS, 2020, 176
[36]   Effective Genome Editing Using CRISPR-Cas9 Nanoflowers [J].
Zhang, Chen ;
Ren, He ;
Liu, Gengqi ;
Li, Jiexin ;
Wang, Xiaojie ;
Zhang, Yumiao .
ADVANCED HEALTHCARE MATERIALS, 2022, 11 (10)
[37]   The Application of CRISPR-Cas9 Genome Editing in Caenorhabditis elegans [J].
Xu, Suhong .
JOURNAL OF GENETICS AND GENOMICS, 2015, 42 (08) :413-421
[38]   Genome characterization and CRISPR-Cas9 editing of a human neocentromere [J].
Palazzo, Antonio ;
Piccolo, Ilaria ;
Minervini, Crescenzio Francesco ;
Purgato, Stefania ;
Capozzi, Oronzo ;
D'Addabbo, Pietro ;
Cumbo, Cosimo ;
Albano, Francesco ;
Rocchi, Mariano ;
Catacchio, Claudia Rita .
CHROMOSOMA, 2022, 131 (04) :239-251
[39]   CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential [J].
Blenke, Erik Oude ;
Evers, Martijn J. W. ;
Mastrobattista, Enrico ;
van der Oost, John .
JOURNAL OF CONTROLLED RELEASE, 2016, 244 :139-148
[40]   Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications [J].
Liu, Chang ;
Zhang, Li ;
Liu, Hao ;
Cheng, Kun .
JOURNAL OF CONTROLLED RELEASE, 2017, 266 :17-26